We investigated the relationship between endocan (a marker of systemic inflammation) and the development of coronary collateral circulation (CCC) as evaluated by coronary angiography in patients with chronic stable angina pectoris. A total of 90 patients (32 poor CCC and 58 good CCC) were included in this study. Endocan levels were determined using a commercially available sandwich enzyme-linked immunosorbent assay kit with high sensitivity and specificity for detection of human endocan. In multivariate logistic regression analysis, low endocan levels were independently associated with good CCC (P < .001). Moreover, low high-sensitivity C-reactive protein levels were also independently associated with good CCC (P = .020). We found an optimal cutoff point for endocan of 1.7 ng/mL; it predicted the presence of good CCC with a sensitivity of 72.4% and specificity of 65.6% (P < .001). The results of the present study suggest that measurement of endocan level may help clinicians to predict the development of CCC in patients with stable coronary artery disease.
SandNPRRehlingMBaggerJPThuesenLFløCNielsenTT. Functional significance of recruitable collaterals during temporary coronary occlusion evaluated by 99mTc-sestamibi single-photon emission computerized tomography. J Am Coll Cardiol. 2000;35(3):624–632.
2.
PohlTHochstrasserPBillingerMFleischMMeierBSeilerC. Influence on collateral flow of recanalising chronic total coronary occlusions: a case–control study. Heart. 2001;86(4):438–443.
3.
MeierPHemingwayHLanskyAJKnappGPittBSeilerC. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J. 2012;33(5):614–621.
4.
WernerGSFerrariMHeinkeS, et al.Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation. 2003;107(15):1972–1977.
5.
ThaulowEErikssenJSandvikLStormorkenHCohnPF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84(2):613–617.
6.
ImhofBAAurrand-LionsM. Angiogenesis and inflammation face off. Nat Med. 2006;12(2):171–172.
7.
AcarGKalkanMEAvciA, et al.The relation of platelet–lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost. 2015;21(5):462–468.
8.
SarrazinSAdamELyonM, et al.Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta Rev Cancer. 2006;1765(1):25–37.
9.
OzakiKToshikuniNGeorgeJ, et al.Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer. 2014;5(3):221–230.
10.
BaltaIBaltaSDemirkolS, et al.Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013;169(5):1066–1070.
11.
BaltaSMikhailidisDPDemirkolS, et al.Endocan-A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension A Pilot Study. Angiology. 2014;65(9):773–777.
12.
CoxLAEvan EijkLTRamakersBPC, et al.Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo. Shock. 2015;43(4):322–326.
13.
LeeHGChoiHYBaeJS. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease. Kidney Int. 2014;86(6):1079–1081.
14.
GersztenREGarcia-ZepedaEALimYC, et al.MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999;398(6729):718–723.
15.
RentropKPCohenMBlankeHPhillipsRA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;5(3):587–592.
16.
KoerselmanJvan der GraafYde JaegerePPGrobbeeDE. Coronary collaterals an important and underexposed aspect of coronary artery disease. Circulation. 2003;107(19):2507–2511.
17.
KurtulADuranM. The correlation between lymphocyte/monocyte ratio and coronary collateral circulation in stable coronary artery disease patients. Biomark Med. 2017;11(1):43–52.
18.
HakimzadehNVerberneHJSiebesMPiekJJ. The future of collateral artery research. Curr Cardiol Rev. 2014;10(1):73.
19.
BéchardDGentinaTDeleheddeM, et al.Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 2001;276(51):48341–48349.
20.
BechardDMeigninVScherpereelA, et al.Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res. 2000;37(5):417–425.
21.
BéchardDScherpereelAHammadH, et al.Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol. 2001;167(6):3099–3106.
22.
ZhangSMZuoLZhouQ, et al.Expression and distribution of endocan in human tissues. Biotech Histochem. 2012;87(3):172–178.
23.
YangJYangQYuSZhangX. Endocan: a new marker for cancer and a target for cancer therapy (Review). Biomed Rep. 2015;3(3):279–283.
24.
DeleheddeMDevenynsLMaurageCAVivèsRR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;2013:705027.
25.
ScherpereelADepontieuFGrigoriuB, et al.Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006;34(2):532–537.
26.
BaltaIBaltaSKoryurekOM, et al.Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol. 2014;70(2):291–296.
27.
AltintasNMutluLCAkkoyunDC, et al.Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea. Angiology. 2016;67(4):364–374.
28.
XiongCZhaoZWChenZY, et al.Elevated human endothelial cell-specific molecule-1 level and its association with coronary artery disease in patients with hypertension. J Investig Med. 2015;63(7):867–870.
29.
KundiHGokMKiziltuncE, et al.The Relationship Between Serum Endocan Levels With the Presence of Slow Coronary Flow A Cross-Sectional Study [Published online November 25, 2015]. Clin Appl Thromb Hemost. pii: 1076029615618024.
30.
KundiHBalunACicekciogluH, et al.Admission endocan level may be a useful predictor of in-hospital mortality and coronary severity index in patients with ST elevation myocardial infarction. Angiology. 2017;68(1):46–51.
31.
ZorkunCAkkayaEZorluATandoğanI. Determinants of coronary collateral circulation in patients with coronary artery disease. Anatol J Cardiol. 2013;13(2):146–151.
32.
GulecSOzdemirAMaradit KremersHDincerIAtmacaYErolC. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur J Clin Invest. 2006;36(6):369–375.
